Literature DB >> 31587352

Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience.

Douglas Tremblay1, Alexander S Vogel2, Erin Moshier3, Ronald Hoffman1, Marina Kremyanskaya1, Selena Zhou1, Thomas Schiano2, John Mascarenhas1.   

Abstract

Entities:  

Keywords:  direct oral anti-coagulant; myeloproliferative; splanchnic vein; thrombosis

Mesh：

Year:  2019        PMID： 31587352      PMCID： PMC7781435          DOI： 10.1111/ejh.13335

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  5 in total

1.  Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases.

Authors:  Sravanthi Lavu; Natasha Szuber; Mythri Mudireddy; Meera Yogarajah; Naseema Gangat; Animesh Pardanani; Curtis A Hanson; Rhett P Ketterling; Aneel A Ashrani; Patrick S Kamath; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2017-12-18       Impact factor: 10.047

Review 2.  Thrombotic disease in the myeloproliferative neoplasms.

Authors:  Anna Falanga; Marina Marchetti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

3.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.

Authors:  S Schulman; C Kearon
Journal:  J Thromb Haemost       Date:  2005-04       Impact factor: 5.824

4.  Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.

Authors:  Walter Ageno; Nicoletta Riva; Sam Schulman; Jan Beyer-Westendorf; Soo Mee Bang; Marco Senzolo; Elvira Grandone; Samantha Pasca; Matteo Nicola Dario Di Minno; Rita Duce; Alessandra Malato; Rita Santoro; Daniela Poli; Peter Verhamme; Ida Martinelli; Pieter Kamphuisen; Doyeun Oh; Elbio D'Amico; Cecilia Becattini; Valerio De Stefano; Gianpaolo Vidili; Antonella Vaccarino; Barbara Nardo; Marcello Di Nisio; Francesco Dentali
Journal:  JAMA Intern Med       Date:  2015-09       Impact factor: 21.873

5.  γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative Neoplasm.

Authors:  Jan Görtzen; Lena M Hunka; Maria Vonnahme; Michael Praktiknjo; Andrea Kaifie; Rolf Fimmers; Christian Jansen; Annkristin Heine; Jennifer Lehmann; Joachim R Goethert; Norbert Gattermann; Eray Goekkurt; Uwe Platzbecker; Peter Brossart; Christian P Strassburg; Tim H Brummendorf; Steffen Koschmieder; Dominik Wolf; Jonel Trebicka
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889
  5 in total
  4 in total

1.  Primary Myelofibrosis in the Prefibrotic Stage Presenting as Portal, Splenic, and Superior Mesenteric Vein Thrombosis: A Case Report and Review of the Literature.

Authors:  Emanuel Dias; Rodrigo Liberal; Pedro Costa-Moreira; Fernando Príncipe; Elsa Fonseca; Guilherme Macedo
Journal:  GE Port J Gastroenterol       Date:  2021-05-04

Review 2.  Overview of Myeloproliferative Neoplasms: History, Pathogenesis, Diagnostic Criteria, and Complications.

Authors:  Douglas Tremblay; Abdulraheem Yacoub; Ronald Hoffman
Journal:  Hematol Oncol Clin North Am       Date:  2021-01-26       Impact factor: 3.722

Review 3.  Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia.

Authors:  Douglas Tremblay; Heidi E Kosiorek; Amylou C Dueck; Ronald Hoffman
Journal:  Front Oncol       Date:  2021-02-16       Impact factor: 6.244

4.  Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients.

Authors:  Tiziano Barbui; Valerio De Stefano; Alessandra Carobbio; Alessandra Iurlo; Alberto Alvarez-Larran; Beatriz Cuevas; Francisca Ferrer Marín; Alessandro M Vannucchi; Francesca Palandri; Claire Harrison; Hassan Sibai; Martin Griesshammer; Massimiliano Bonifacio; Elena M Elli; Chiara Trotti; Steffen Koschmieder; Giuseppe Carli; Giulia Benevolo; Jean-Christophe Ianotto; Swati Goel; Anna Falanga; Silvia Betti; Daniele Cattaneo; Eduardo Arellano-Rodrigo; Lara Mannelli; Nicola Vianelli; Andrew Doyle; Vikas Gupta; Kai Wille; Douglas Tremblay; John Mascarenhas
Journal:  Leukemia       Date:  2021-05-19       Impact factor: 11.528
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.